Mechanistic Insight of Drug Resistance with Special Focus on Iron in Estrogen Receptor Positive Breast Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4316|15|12|1141-1157

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.15, Iss.12, 2014-12, pp. : 1141-1157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Estrogen Receptor-Positive Breast Cancer

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 596-604

Bentham Science Publishers

Access to resources Recommend Favorite

Endocrine Disruptor Agent Nonyl Phenol Exerts An Estrogen-like Transcriptional Activity on Estrogen Receptor Positive Breast Cancer Cells

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 630-640

Bentham Science Publishers

Access to resources Recommend Favorite

Active smoking and the risk of estrogen receptor-positive and triple-negative breast cancer among women ages 20 to 44 years

By Kawai Masaaki   Malone Kathleen E.   Tang Mei-Tzu C.   Li Christopher I.  

Cancer, Vol. 120, Iss. 7, 2014-04 ,pp. : 1026-1034

Blackwell Publishing

Access to resources Recommend Favorite

Efficacy of UFT plus Tamoxifen for Estrogen-Receptor-Positive Breast Cancer and Tamoxifen plus UFT for Estrogen-Receptor-Negative Breast Cancer: Adjuvant Therapy after Administration of Mitomycin

By Ogita M.  

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 689-699

Adis International

Access to resources Recommend Favorite

Everolimus in the treatment of hormone receptor-positive breast cancer

By Chavez-MacGregor Mariana   Gonzalez-Angulo Ana Maria  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1835-1843

Informa Healthcare

Access to resources Recommend Favorite